These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 25014180)

  • 41. Faecal microbiota transplantation for recurrent Clostridioides difficile infection: experience with lyophilized oral capsules.
    Reigadas E; Bouza E; Olmedo M; Vázquez-Cuesta S; Villar-Gómara L; Alcalá L; Marín M; Rodríguez-Fernández S; Valerio M; Muñoz P
    J Hosp Infect; 2020 Jun; 105(2):319-324. PubMed ID: 31883938
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Durability and Long-term Clinical Outcomes of Fecal Microbiota Transplant Treatment in Patients With Recurrent Clostridium difficile Infection.
    Mamo Y; Woodworth MH; Wang T; Dhere T; Kraft CS
    Clin Infect Dis; 2018 May; 66(11):1705-1711. PubMed ID: 29272401
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fecal microbiota transplantation for the treatment of Clostridium difficile infection.
    Rao K; Safdar N
    J Hosp Med; 2016 Jan; 11(1):56-61. PubMed ID: 26344412
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Maintaining standard volumes, efficacy and safety, of fecal microbiota transplantation for C. difficile infection during the COVID-19 pandemic: A prospective cohort study.
    Ianiro G; Bibbò S; Masucci L; Quaranta G; Porcari S; Settanni CR; Lopetuso LR; Fantoni M; Sanguinetti M; Gasbarrini A; Cammarota G
    Dig Liver Dis; 2020 Dec; 52(12):1390-1395. PubMed ID: 33004295
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fecal microbiota transplantation for treatment of recurrent C. difficile infection: An updated randomized controlled trial meta-analysis.
    Hui W; Li T; Liu W; Zhou C; Gao F
    PLoS One; 2019; 14(1):e0210016. PubMed ID: 30673716
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Microbial Engraftment and Efficacy of Fecal Microbiota Transplant for Clostridium Difficile in Patients With and Without Inflammatory Bowel Disease.
    Hirten RP; Grinspan A; Fu SC; Luo Y; Suarez-Farinas M; Rowland J; Contijoch EJ; Mogno I; Yang N; Luong T; Labrias PR; Peter I; Cho JH; Sands BE; Colombel JF; Faith JJ; Clemente JC
    Inflamm Bowel Dis; 2019 May; 25(6):969-979. PubMed ID: 30852592
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Systematic review with meta-analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection.
    Quraishi MN; Widlak M; Bhala N; Moore D; Price M; Sharma N; Iqbal TH
    Aliment Pharmacol Ther; 2017 Sep; 46(5):479-493. PubMed ID: 28707337
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Changes in microbial ecology after fecal microbiota transplantation for recurrent C. difficile infection affected by underlying inflammatory bowel disease.
    Khanna S; Vazquez-Baeza Y; González A; Weiss S; Schmidt B; Muñiz-Pedrogo DA; Rainey JF; Kammer P; Nelson H; Sadowsky M; Khoruts A; Farrugia SL; Knight R; Pardi DS; Kashyap PC
    Microbiome; 2017 May; 5(1):55. PubMed ID: 28506317
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Long-term Efficacy and Safety of Fecal Microbiota Transplant for Recurrent, Severe, and Complicated Clostridium difficile Infection in 146 Elderly Individuals.
    Agrawal M; Aroniadis OC; Brandt LJ; Kelly C; Freeman S; Surawicz C; Broussard E; Stollman N; Giovanelli A; Smith B; Yen E; Trivedi A; Hubble L; Kao D; Borody T; Finlayson S; Ray A; Smith R
    J Clin Gastroenterol; 2016; 50(5):403-7. PubMed ID: 26352106
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Faecal microbiota transplantation plus selected use of vancomycin for severe-complicated Clostridium difficile infection: description of a protocol with high success rate.
    Fischer M; Sipe BW; Rogers NA; Cook GK; Robb BW; Vuppalanchi R; Rex DK
    Aliment Pharmacol Ther; 2015 Aug; 42(4):470-6. PubMed ID: 26096320
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Retrospective Comparison of Fecal Microbial Transplantation Methods for Recurrent Clostridium Difficile Infection.
    Cohen NA; Livovsky DM; Yaakobovitch S; Ben Yehoyada M; Ben Ami R; Adler A; Guzner-Gur H; Goldin E; Santo ME; Halpern Z; Paz K; Maharshak N
    Isr Med Assoc J; 2016 Oct; 18(10):594-599. PubMed ID: 28471618
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk Factors that Predict the Failure of Multiple Fecal Microbiota Transplantations for Clostridioides difficile Infection.
    Allegretti JR; Mehta SR; Kassam Z; Kelly CR; Kao D; Xu H; Fischer M
    Dig Dis Sci; 2021 Jan; 66(1):213-217. PubMed ID: 32170474
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The 'ins and outs' of faecal microbiota transplant for recurrent Clostridium difficile diarrhoea at Wits Donald Gordon Medical Centre, Johannesburg, South Africa.
    Lee S; Drennan K; Simons G; Hepple A; Karlsson K; Lowman W; Gaylard PC; McNamara L; Fabian J
    S Afr Med J; 2018 Apr; 108(5):403-407. PubMed ID: 29843854
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Asymptomatic Clostridium difficile carriage rate post-fecal microbiota transplant is low: a prospective clinical and stool assessment.
    Allegretti JR; Allegretti AS; Phelps E; Xu H; Kassam Z; Fischer M
    Clin Microbiol Infect; 2018 Jul; 24(7):780.e1-780.e3. PubMed ID: 29104169
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Colonoscopic versus nasogastric fecal transplantation for the treatment of Clostridium difficile infection: a review and pooled analysis.
    Postigo R; Kim JH
    Infection; 2012 Dec; 40(6):643-8. PubMed ID: 22847629
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Systematic Review with Meta-Analysis: Fecal Microbiota Transplantation for Severe or Fulminant Clostridioides difficile.
    Tixier EN; Verheyen E; Luo Y; Grinspan LT; Du CH; Ungaro RC; Walsh S; Grinspan AM
    Dig Dis Sci; 2022 Mar; 67(3):978-988. PubMed ID: 33748913
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fecal microbiota transplantation for recurrent Clostridium difficile infection: Experience, protocol, and results.
    Reigadas E; Olmedo M; Valerio M; Vázquez-Cuesta S; Alcalá L; Marín M; Muñoz P; Bouza E
    Rev Esp Quimioter; 2018 Oct; 31(5):411-418. PubMed ID: 30221898
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fecal microbiota transplantation - methods of treatment of recurrent Clostridium difficile infections and other diseases.
    Juszczuk K; Grudlewska K; Mikucka A; Gospodarek E
    Postepy Hig Med Dosw (Online); 2017 Mar; 71(0):220-226. PubMed ID: 28345530
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Predictors of failure after single faecal microbiota transplantation in patients with recurrent Clostridium difficile infection: results from a 3-year, single-centre cohort study.
    Ianiro G; Valerio L; Masucci L; Pecere S; Bibbò S; Quaranta G; Posteraro B; Currò D; Sanguinetti M; Gasbarrini A; Cammarota G
    Clin Microbiol Infect; 2017 May; 23(5):337.e1-337.e3. PubMed ID: 28057560
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Faecal microbiota transplantation for Clostridioides difficile infection].
    Waldbaum C; López F; Antelo P; Sorda J
    Medicina (B Aires); 2020; 80(6):633-639. PubMed ID: 33254107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.